Editorial:. Moss S. Screening for breast cancer in India – is it an appropriate strategy J Natl Cancer Inst 2008; 100:1270-1271 the Journal of the National Cancer? Institute Oxford University Press Oxford University Press and with the with the National Cancer Institute.
Researchers identify genes that better predict response to BRAF inhibitors in patients with advanced melanoma CouldGenetic analysis of tumors from patients with advanced melanoma can clue researchers how well patients treatment treatment that targets the growth-promoting protein called BRAF, a researcher from the Perelman School of Medicine at the University of Pennsylvania is the 6th on Monday In June report at the annual meeting of the American Society of Clinical Oncology. Looking outside the BRAF gene, the researchers found the loss of tumor suppressor gene PTEN seems with patient response to GSK436, the lead researcher even more personalized approaches to melanoma therapy could help be related.
In an accompanying editorial, Sue Moss, of the Institute of cancer Research in Surrey, even though studies show that mammography screening can breast cancer mortality show decrease, no such data for the clinical breast exist.The national supervisory data the we have collected from sites across the country confirms that OraQuick ADVANC leads with oral fluid at a very high accuracy. We are very pleased with the excellent performance happy the OraQuick ADVANC which have been found was an extremely valuable tool in the fight against HIV / AIDS. .. Throughout Germany on aggregate data on of the Company concerned 2007 to May 2008 2007 to May 2008 prepared based on more than 250,000 oral fluid reports reported with a specifity of 99.8 percent. The data was generated at more than 400 sites , including public Kliniken, community-based organizations, hospitals, and publicity settings at. – OraSure one priority and has always been a to make sure our clients to be satisfied with the performance of of our products, said Douglas A.
Above all, thanks to rapid HIV testing, health care providers has able to to screen for more and more people and ensuring diagnosis diagnosed by HIV in care immediately. .. OraSure Technologies, Inc. known to total of nationally performance information in 2007 and beyond first five months of 2008, the show that has widespread rapid HIV test-1/2 antibody screening test, OraQuick ADVANC, extreme accuracy with oral fluid – is at prices which is within these U.S. Food and and performance range expected to of the product.
Oral fluid test to have a very important part HIV prevention to New York and all over the nation continues, Michel said.